HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Two-year clinical outcomes after large coronary stent (4.0 mm) placement: comparison of bare-metal stent versus drug-eluting stent.

AbstractBACKGROUND:
The absolute benefit of drug-eluting stents (DES) in low-risk patients and lesions is not well established.
HYPOTHESIS:
The long term clinical outcomes after percutaneous coronary intervention in a single coronary artery disease may not be affected by the type of stent.
METHODS:
This study assessed and compared 2-year clinical outcomes of 304 consecutive patients (147 BMS patients and 157 DES patients) treated with a single coronary stent (4.0 mm) for single de novo large coronary artery disease in 3 referral cardiac centers. The primary outcome was a composite of major adverse cardiac events at 2 years after the index procedure.
RESULTS:
The reference vessel diameter was similar in both groups (3.92 ± 0.29 mm in BMS vs 3.95 ± 0.24 mm in DES, P = 0.50). Late loss was larger in the BMS group (1.04 ± 0.83 mm vs 0.73 ± 0.91 mm in DES, P = 0.03). The incidence of major adverse cardiac events at the 2-year clinical follow-up was very low, 24 of 304 patients (7.9%), regardless of stent type deployed (7.5% in BMS vs 8.3% in DES, P = 0.83). The rate of target vessel revascularization was also similar in both groups (4.8% in BMS vs 5.7% in DES, P = 0.80).
CONCLUSIONS:
Two-year clinical outcomes after PCI with a single large coronary stent (4.0 mm) were excellent. The clinical outcomes were not affected by the type of stent used.
AuthorsHyun-Tae Kim, Chang-Wook Nam, Seung-Ho Hur, Kwon-Bae Kim, Sang-Hee Lee, Geu-Ru Hong, Jong-Seon Park, Young-Jo Kim, Ung Kim, Tae-Hyun Yang, Doo-Il Kim, Dong-Soo Kim
JournalClinical cardiology (Clin Cardiol) Vol. 33 Issue 10 Pg. 620-625 (Oct 2010) ISSN: 1932-8737 [Electronic] United States
PMID20960536 (Publication Type: Comparative Study, Journal Article, Multicenter Study)
Copyright© 2010 Wiley Periodicals, Inc.
Chemical References
  • Tubulin Modulators
  • zotarolimus
  • Paclitaxel
  • Sirolimus
Topics
  • Coronary Angiography
  • Coronary Stenosis (diagnostic imaging, surgery)
  • Drug-Eluting Stents
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Paclitaxel (pharmacology)
  • Postoperative Period
  • Prosthesis Design
  • Retrospective Studies
  • Severity of Illness Index
  • Sirolimus (analogs & derivatives, pharmacology)
  • Time Factors
  • Treatment Outcome
  • Tubulin Modulators (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: